Showing results (131-140 of 240) with videos related to

Sort By:
Pageof 24
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 23, 2022
Real-World Analysis of Thromboembolic Events and Mortality of COVID-19 Outpatients in the United StatesW Frank Peacock, James M Crawford, Yen-Wen Cindy Chen, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|December 1, 2022
Occurrence of Thromboembolic Events and Mortality Among Hospitalized Coronavirus 2019 Patients: Large Observational Cohort Study of Electronic Health RecordsAlex C Spyropoulos, James M Crawford, Yen-Wen Cindy Chen, et al.
Circulation|May 26, 2018
Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial FibrillationBassel Nazha, Bhavi Pandya, Jessica Cohen, et al.
Joint Commission Journal on Quality and Patient Safety|August 2, 2018
Defining Minimum Necessary Anticoagulation-Related Communication at Discharge: Consensus of the Care Transitions Task Force of the New York State Anticoagulation CoalitionDarren Triller, Anne Myrka, John Gassler, et al.
The Annals of Pharmacotherapy|October 18, 2014
Features of electronic health records necessary for the delivery of optimized anticoagulant therapy: consensus of the EHR Task Force of the New York State Anticoagulation CoalitionAlex C Spyropoulos, Anna Viscusi, Nakul Singhal, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 16, 2019
Proportion of US Hospitalized Medically Ill Patients Who May Qualify for Extended ThromboprophylaxisBenjamin Miao, Bhavana Chalupadi, Brendan Clark, et al.
Thrombosis and Haemostasis|November 23, 2023
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled TrialsJudith Hsia, Alex C Spyropoulos, Gregory Piazza, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|October 27, 2022
Extended Thromboprophylaxis in Hospitalized Patients with Heart Failure: A Post Hoc Analysis of the MAGELLAN StudyAlex C Spyropoulos, Gary E Raskob, Theodore E Spiro, et al.
Journal of Thrombosis and Haemostasis : JTH|August 11, 2024
Universal clinical decision support tool for thromboprophylaxis in hospitalized COVID-19 patients: post hoc analysis of the IMPROVE-DD cluster randomized trialMark Goldin, Nikolaos Tsaftaridis, Ioannis Koulas, et al.
Thrombosis Research|October 2, 2013
Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient populationCharles E Mahan, Maxine D Fisher, Roger M Mills, et al.
Pageof 24